Streptococcal Toxic Shock-like Syndrome

Internal Medicine

Volumn 39, Issue 3, 2000, Pages 195-196

  Shimizu, Yoshikata ^a  

^a ASAHI GENERAL HOSPITAL   (Japan)

Author keywords

multiple organ failure; septic shock; Streptococcus pyogenes

Indexed keywords

ANTIINFECTIVE AGENT;

CROSS INFECTION; DRUG COMBINATION; HUMAN; INCIDENCE; ISOLATION AND PURIFICATION; MICROBIOLOGY; NOTE; PASSIVE IMMUNIZATION; SEPTIC SHOCK; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PYOGENES;

ANTI-BACTERIAL AGENTS; CROSS INFECTION; DRUG THERAPY, COMBINATION; HUMANS; IMMUNIZATION, PASSIVE; INCIDENCE; SHOCK, SEPTIC; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES;

EID: 0034150902     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.39.195     Document Type: Article

References (5)

1. The working group on severe streptococcal infections. Defining the group A streptococcal toxic shock syndrome: Rationale and consensus definition. JAMA 269: 390–391, 1993 (comment).
2. Shimizu Y., Igarashi H., Murai T., et al. Report of surveillance on streptococcal toxic shock syndrome in Japan and presentation of the criteria. Kansensshogaku Zasshi 72: 258–265, 1998 (in Japanese, Abstract in English).
3. Saeki A., Yoneda M., Degawa M., et al. Toxic shock-like syndrome caused by T serotype B3264 streptococcus. Intern Med 39: 266–269, 2000.
4. Stevens D.L., Bryant A.E., Yan S. Invasive group A streptococcal infection: new concepts in antibiotic treatment. Int J Antimicrobial Agent 4: 297–301, 1994.
5. Barry W., Hudgings L., Donta S.T., Pesanti E.L. Intravenous immunoglobulin therapy for toxic shock syndrome. JAMA 267: 3315–3316, 1992.